These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cortisol and Brain-Derived Neurotrophic Factor Levels Prior to Treatment in Children With Obsessive-Compulsive Disorder. Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Alaca R J Clin Psychiatry; 2016 Jul; 77(7):e855-9. PubMed ID: 27314567 [TBL] [Abstract][Full Text] [Related]
3. A cytokine study of adult patients with obsessive-compulsive disorder. Fontenelle LF; Barbosa IG; Luna JV; de Sousa LP; Abreu MN; Teixeira AL Compr Psychiatry; 2012 Aug; 53(6):797-804. PubMed ID: 22300901 [TBL] [Abstract][Full Text] [Related]
4. Increased serum brain-derived neurotrophic factor and adrenocorticotropic hormone levels are associated with obsessive compulsive disorder in medication‑free children. Bilgiç A; Sertdemir M; Kılınç İ; Akça ÖF Eur Child Adolesc Psychiatry; 2022 Feb; 31(2):325-335. PubMed ID: 33389158 [TBL] [Abstract][Full Text] [Related]
5. Neurotrophic factors in obsessive-compulsive disorder. Fontenelle LF; Barbosa IG; Luna JV; Rocha NP; Silva Miranda A; Teixeira AL Psychiatry Res; 2012 Oct; 199(3):195-200. PubMed ID: 22494702 [TBL] [Abstract][Full Text] [Related]
6. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder. Karagüzel EÖ; Arslan FC; Uysal EK; Demir S; Aykut DS; Tat M; Karahan SC Compr Psychiatry; 2019 Feb; 89():61-66. PubMed ID: 30594753 [TBL] [Abstract][Full Text] [Related]
8. Serum zonulin and claudin-5 levels in children with obsessive-compulsive disorder. Işık Ü; Aydoğan Avşar P; Aktepe E; Doğuç DK; Kılıç F; Büyükbayram Hİ Nord J Psychiatry; 2020; 74(5):346-351. PubMed ID: 31961248 [No Abstract] [Full Text] [Related]
9. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial. Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832 [TBL] [Abstract][Full Text] [Related]
10. The relationship between Toxoplasma gondii IgG antibodies and generalized anxiety disorder and obsessive-compulsive disorder in children and adolescents: a new approach. Akaltun İ; Kara SS; Kara T Nord J Psychiatry; 2018 Jan; 72(1):57-62. PubMed ID: 28990850 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. Rodríguez N; Morer A; González-Navarro EA; Serra-Pages C; Boloc D; Torres T; García-Cerro S; Mas S; Gassó P; Lázaro L J Neuroinflammation; 2017 Dec; 14(1):261. PubMed ID: 29284508 [TBL] [Abstract][Full Text] [Related]
12. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder. Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880 [TBL] [Abstract][Full Text] [Related]
13. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder. Wang Y; Zhang H; Li Y; Wang Z; Fan Q; Yu S; Lin Z; Xiao Z J Affect Disord; 2015 Nov; 186():7-12. PubMed ID: 26209750 [TBL] [Abstract][Full Text] [Related]
14. Comparing family accommodation in pediatric obsessive-compulsive disorder, anxiety disorders, and nonanxious children. Lebowitz ER; Scharfstein LA; Jones J Depress Anxiety; 2014 Dec; 31(12):1018-25. PubMed ID: 24677578 [TBL] [Abstract][Full Text] [Related]
15. Severe symptoms predict salivary interleukin-6, interleukin-1β, and tumor necrosis factor-α levels in children and youth with obsessive-compulsive disorder. Westwell-Roper C; Best JR; Naqqash Z; Au A; Lin B; Lu C; Shao L; Beasley CL; Stewart SE J Psychosom Res; 2022 Apr; 155():110743. PubMed ID: 35190349 [TBL] [Abstract][Full Text] [Related]
16. 8-F2-isoprostane, thioredoxin and thioredoxin reductase levels in children with obsessive-compulsive disorder. Bilgiç A; Çolak Sivri R; Kılınç İ Nord J Psychiatry; 2018 Oct; 72(7):484-488. PubMed ID: 29927677 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: a case-control study. Maina G; Rosso G; Zanardini R; Bogetto F; Gennarelli M; Bocchio-Chiavetto L J Affect Disord; 2010 Apr; 122(1-2):174-8. PubMed ID: 19664825 [TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients. Wang Y; Mathews CA; Li Y; Lin Z; Xiao Z J Affect Disord; 2011 Sep; 133(1-2):305-10. PubMed ID: 21616543 [TBL] [Abstract][Full Text] [Related]
20. Serum Cytokine Profiles of Children with Obsessive-Compulsive Disorder Shows the Evidence of Autoimmunity. Şimşek Ş; Yüksel T; Çim A; Kaya S Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27207913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]